Clinical trial
Navrongo Drug Options for IPT in Pregnancy Trial
NCT00146783 · London School of Hygiene and Tropical Medicine, Other · Completed
Key facts
| NCT number | NCT00146783 |
|---|---|
| Title | Navrongo Drug Options for IPT in Pregnancy Trial |
| Official title | Efficacy of Sulphadoxine-pyrimethamine and Amodiaquine Alone or in Combination as Intermittent Preventive Treatment in Pregnancy in the Kassena-Nankana District of Ghana: a Randomized Controlled Trial |
| Lead sponsor | London School of Hygiene and Tropical Medicine, Other |
| Collaborators | Ministry of Health, Ghana |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Malaria |
| Intervention type | Drug |
| Interventions | Sulphadoxine-pyrimethamine, amodiaquine |
| Enrollment | 3,642 |
| Start date | Jun 1, 2004 |
| Completion | Feb 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | Ghana |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: